Prevalence and Characteristics of Sleep Apnea in Intensive Care Unit Survivors After SARS-CoV-2 Pneumonia.

Date publication

décembre 2022

Journal

Nature and science of sleep

Auteurs

Membres identifiés du Cancéropôle Est :
Dr PAGET-BAILLY Sophie , Pr WESTEEL Virginie , Mme MEURISSE Aurélia

Tous les auteurs :
Traore I, Eberst G, Claudé F, Laurent L, Meurisse A, Paget-Bailly S, Roux-Claudé P, Jacoulet P, Barnig C, Martarello R, Poirson B, Bouiller K, Chirouze C, Behr J, Grillet F, Ritter O, Pili-Floury S, Winiszewski H, Samain E, Capellier G, Westeel V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36578669

Résumé

Sleep apnea (SA) was reported as possibly exacerbating symptoms of COVID-19, a disease induced by SARS-CoV-2 virus. The same comorbidities are common with both pathologies. This study aimed to estimate the prevalence, characteristics of SA and variation in AHI three months after severe COVID-19 requiring intensive care unit (ICU) admission.

Mots clés

SARS-CoV-2, intensive care unit, obstructive sleep apnea syndrome, pneumonia

Référence

Nat Sci Sleep. 2022 12 22;14:2213-2225